Exabis Library
Welcome to the e-CCO Library!
P0671: Supporting vedolizumab treatment throughout pregnancy: Insights from a population pharmacokinetic model
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0672: Comparative Efficacy of Medical Therapies in Reducing the Risk of Post Operative Recurrence in Crohn’s Disease (PORCD): A Systematic Review and Network Meta-analysis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0673: Proactive switching to subcutaneous vedolizumab in Inflammatory bowel disease correlates with raised trough levels and confers a clinical benefit: a real-world experience.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0674: Development of a screening tool to address dietary habits in persons with IBD in Germany
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0675: Ultrasonographic assessment of response in hospitalized patients with acute severe ulcerative colitis
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0676: Inborn Errors of Immunity Associated with Inflammatory Bowel Disease at a Tertiary Care Centre
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0677: Population-Based Analysis of 30-Day Postoperative Course in Crohn’s Disease Patients Undergoing Primary Bowel Resection
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0678: Iron deficiencyx7x7x7 with or without anaemiax7x7x7 in Inflammatory Bowel Disease remains an undermanaged issue: Crohn’s Colitis Cure Data Insights Program
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0679: Therapeutic Drug Monitoring of the Infliximab (anti-TNF) Level with Bedside Kit in Inflammatory Bowel Disease
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P067: Angiogenic characterisation of Crohn’s disease mesenteric adipose tissue
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P067: Fractal analysis of extracellular matrix as a new histological method for observer-independent quantification of intestinal fibrosis in Crohn's Disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:48 AM
P067: Human colonic subepithelial myofibroblasts from IBD patients demonstrate a differential expression of Th-related cytokine receptors compared with healthy controls
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P067: Human intestinal CD103+SIRPα+ conventional dendritic cells from patients with Crohn´s disease prime IL-17+ T-cells.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P067: Molecular profiling of early Crohn's disease reveals a prominent role for WNT5A
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P067: Proliferating intestinal macrophage populations in human inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P067: The effect of a probiotic mix on mucosal healing and fibrotic responses in healthy colonic subepithelial myofibroblasts.
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P068 Erythrocyte and reticulocyte parameters in children with inflammatory bowel diseases
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P0680: Upadacitanib in Inflammatory Bowel Disease: Evaluating the risk of neutropenia and impact of thiopurine exposure
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0681: Filgotinib for active Ulcerative Colitis in clinical practice - Effective treatment at week 8 is associated with higher clinical remission and persistence rates at Week 52 -
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM
P0682: Effectivenessx7x7x7 safety and predictors of response to vedolizumab as first- or second-line biological therapy in patients with ulcerative colitis: A real-world observational multicenter study.
2025
ECCO'25
Monday, 10 February 2025, 2:00 PM